MoonLake Immunotherapeutics (NAS:MLTX)
$ 39.44 -2.53 (-6.03%) Market Cap: 2.48 Bil Enterprise Value: 2.10 Bil PE Ratio: 0 PB Ratio: 4.81 GF Score: 22/100